I-MED PHARMA USA PARTNERS WITH DRYEYE RESCUE TO DISTRIBUTE ITS INNOVATIVE DRY EYE PRODUCT PORTFOLIO IN THE UNITED STATES.
Montreal, February 3, 2022 (Globe Newswire) With the recent launch of its line of dry…
CORPORATE OFFICE RELOCATION FOR I-MED PHARMA
January 24, 2022 I-MED Pharma continues to grow and expand! We are pleased to announce…
NTC and I-MED Pharma form strategic partnership to bring the leading dry eye ointment with lanolin and mineral oil to the United States market.
Montreal, December 15, 2021 (GLOBE NEWSWIRE) NTC Srl, R&D driven pharmaceutical company with headquarters in…
I-MED Pharma USA Gains Exclusive Distribution Rights for ESW Vision’s E>Eye and Tearcheck® in the United States
MONTREAL, December 9, 2021 (GLOBE NEWSWIRE) I-MED Pharma Inc., a Canadian company specializing in dry…
I-MED PHARMA USA ANNOUNCES MICHELLE SCHNABEL AS VP BUSINESS DEVELOPMENT
Montreal, November 9, 2021 (Globe Newswire) With the recent expansion into the United States, I-MED…
I-MED PHARMA USA ANNOUNCES BRENT JONES AS CHIEF COMMERCIAL OFFICER
Montreal, November 8, 2021 (Globe Newswire) With the recent expansion into the United States, I-MED…
I-MED PHARMA IS NAMED AS A TOP OPHTHALMIC DEVICE PROVIDER OF 2021!
October 7, 2021 (Montreal, QC, Canada) Article published in September issue of MEDTECH OUTLOOK Magazine…
Women rock-stars in optical
Montreal, QC, Canada Article published in Optical Prism October issue ANNE MARIE QUENNEVILLE – VP…
Dechra Veterinary Products Partners with I-MED Pharma
Dechra Veterinary Products is pleased to announce its exclusive marketing, sales, and distribution agreement with…
I-MED PHARMA OPENS EUROPEAN WAREHOUSE
I-MED Pharma, Inc., a Canadian company specializing in dry eye diagnosis and management is proud…
I-MED PHARMA TRANSITIONS ITS SURGICAL PRODUCT PORTFOLIO TO KEIR SURGICAL
I-MED Pharma, Inc., a Canadian company specializing in dry eye diagnosis and management is proud…
I-MED PHARMA IS NAMED AS A TOP OPHTHALMIC SOLUTION PROVIDER OF 2020!
December 9, 2020, (Montreal, QC, Canada) Article published in December issue of MEDTECH OUTLOOK Magazine…
I-DROP® PUR GEL NOW AVAILABLE IN THE UAE THROUGH PARTNERSHIP WITH PHARMALINK
MONTREAL, NOVEMBER 20, 2020 I-MED Pharma, Inc., a Canadian company specializing in dry eye diagnosis…
I-MED Pharma launches tearcheck® in Canada – A new standard in dry eye analysis!
I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, announces the…
I-MED Pharma Launches the Latest Addition to Their Dry Eye Product Line, I-DEFENCE® – a Night-time Ointment for Severe Chronic Dry Eye Disease
I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, announced today…
Patented IRPL® Technology Now Available in Canada! E>Eye Laser Gains Health Canada Approval with Exclusive Canadian Distribution Rights for I-MED Pharma
I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, is proud…
I-MED PHARMA TO LAUNCH ITS MOST ADVANCED ARTIFICIAL TEAR TO DATE WITH I-DROP® MGD
MONTREAL, February 03, 2020 (GLOBE NEWSWIRE) – I-MED Pharma Inc., a Canadian company specializing in…
Federal Court of Appeal Upholds I-MED Pharma’s Patent Win Against TearLab
Montreal, June 17, 2019 (GLOBE NEWSWIRE) – I-MED Pharma Inc., a Canadian company specializing in…
I-LID ’N LASH®, I-LID ’N LASH® PLUS & I-PEN® NOW AVAILABLE IN SWITZERLAND THROUGH PARTNERSHIP WITH PROLENS AG
MONTREAL, May 28, 2019 I-MED Pharma, Inc., a Canadian company specializing in dry eye diagnosis…
I-MED Pharma Becomes the Authorized Canadian Distributor for the OrCam MyEye 2
MONTREAL, April 10, 2019 (GLOBE NEWSWIRE) – I-MED Pharma, Inc., a Canadian company specializing in…
I-MED Pharma Celebrates 30 Years of Providing OSD Solutions to the Global Eye Care Community
MONTREAL, April 1, 2019 (GLOBE NEWSWIRE) – I-MED Pharma Inc., a Canadian company specializing in…
I-PEN® Osmolarity System Now Available in Brazil Through Partnership with DryCom
MONTREAL, March 26, 2019 (GLOBE NEWSWIRE) – I-MED Pharma, Inc., a Canadian company specializing in…
I-MED Pharma Partners with Iogen Oy to Introduce I-DROP®, I-LID ’N LASH®, I-RELIEFTM Therapeutic Eye Mask and the I-PEN® Osmolarity System to the Finnish Market.
MONTREAL, November 1st, 2018 (GLOBE NEWSWIRE) – I-MED Pharma Inc., a Canadian company specializing in…
I-MED Pharma Partners with Quidel to Introduce I-LID ’N LASH®, I-RELIEF® and SMTube® to the U.S Market.
I-MED Pharma Partners with Quidel to Introduce I-LID ’N LASH®, I-RELIEF® and SMTube® to the…
I-MED Pharma Partners with Simovision to Bring the I-PEN® Osmolarity System to Belgium, Luxembourg & the Netherlands
I-MED Pharma Partners with Simovision to Bring the I-PEN® Osmolarity System to Belgium, Luxembourg &…
Quebec Government Supports I-MED Pharma by Helping Fund International Expansion
West Island businesses get financial boost from Quebec Government The Quebec government is giving several…
I-MED Pharma Inc. Announces Partnership with Medicals International
MONTREAL, July 23, 2018 (GLOBE NEWSWIRE) – I-MED Pharma Inc., a Canadian company specializing in…
I-MED Pharma to Bring Clinically Proven E>Eye IRPL® Technology to Canada
Montreal, May 24, 2018 (Globe Newswire) – I-MED Pharma Inc., a Canadian company specializing in…
I-MED Pharma’s I-PEN® Receives Regulatory Approval from INVIMA in Colombia and ANMAT in Argentina
Montreal, April 3, 2018 (Globe Newswire) – I-MED Pharma Inc., a Canadian Company specializing in…
I-MED Pharma’s I-PEN® Does Not Infringe the TearLab Patent
Montreal, February 20, 2018 (GLOBE NEWSWIRE) – On February 14th TearLab issued a press release…
I-MED Pharma Wins Patent Case Against TearLab
Montreal, February 13, 2018 (GLOBE NEWSWIRE) – I-MED Pharma Inc., announced today that TearLab’s efforts…
I-MED Pharma partners with OCuSOFT to bring the I-PEN® Osmolarity System to the U.S.A.
Montreal, January 8, 2018 (Globe Newswire) – I-MED Pharma Inc., a Canadian company specializing in…
